Direct Human Contact with Siloxanes (Silicones) – Safety or Risk Part 1. Characteristics of Siloxanes (Silicones) by Krystyna Mojsiewicz-Pieńkowska et al.
fphar-07-00132 May 26, 2016 Time: 12:51 # 1
REVIEW
published: 30 May 2016
doi: 10.3389/fphar.2016.00132
Edited by:
Hani El-Nezami,
Royal Melbourne Institute
of Technology University, Australia
Reviewed by:
Maria Ada Malvindi,
Italian Institute of Technology, Italy
Chit Shing Jackson Woo,
SGS Hong Kong Limited, China
*Correspondence:
Krystyna Mojsiewicz-Pien´kowska
kpienk@gumed.edu.pl
Specialty section:
This article was submitted to
Predictive Toxicology,
a section of the journal
Frontiers in Pharmacology
Received: 22 March 2016
Accepted: 09 May 2016
Published: 30 May 2016
Citation:
Mojsiewicz-Pien´kowskaK,
JamrógiewiczM, SzymkowskaK
andKrenczkowskaD (2016) Direct
Human Contact with Siloxanes
(Silicones) – Safety or Risk Part 1.
Characteristics of Siloxanes
(Silicones). Front. Pharmacol. 7:132.
doi: 10.3389/fphar.2016.00132
Direct Human Contact with Siloxanes
(Silicones) – Safety or Risk Part 1.
Characteristics of Siloxanes
(Silicones)
Krystyna Mojsiewicz-Pien´kowska*, Marzena Jamrógiewicz, Katarzyna Szymkowska and
Dominika Krenczkowska
Department of Physical Chemistry, Faculty of Pharmacy with Subfaculty of Laboratory Medicine, Medical University of
Gdan´sk, Gdan´sk, Poland
Siloxanes are commonly known as silicones. They belong to the organosilicon
compounds and are exclusively obtained by synthesis. Their chemical structure
determines a range of physicochemical properties which were recognized as unique.
Due to the susceptibility to chemical modifications, ability to create short, long or
complex polymer particles, siloxanes found an application in many areas of human life.
Siloxanes differ in particle size, molecular weight, shape and chemical groups. As a
result, this determines the different physico-chemical properties, that directly affect the
safety or the risk of their use. The areas that can be a source of danger to human health
will be commented in this paper.
Keywords: siloxanes, methylsiloxanes, low molecular siloxanes, silicones, physical properties of siloxanes,
chemical properties of siloxanes, safety of using silicones, risk of using silicones
INTRODUCTION
Siloxanes (silicones) constitute a group of low molecular weight compounds, organosilicon
oligomers and polymers, which play a very important role in human life. The dynamic development
of silicones technology can be observed last years, which caused that more than 150,000 of
practical applications have been registered, including pharmaceutical, medical, cosmetic, and food
production (CES – Silicones Europe, 2008; Chemical Economics Handbook, 2013; Tran et al., 2015;
Xu et al., 2015). It should be emphasized that the global capacity of siloxanes production in 2002
amounted to 2,000,000 tons, and currently it is more than 8,000,000 tons (Tran et al., 2015). Since
2002 annual average production amount of only cyclic methylsiloxanes was 470,000 tons in the
US, and 800,000 tons in China (Tran et al., 2015; Xu et al., 2015). The largest consumption of
silicones was noted in China, Western Europe and North America. It is estimated that the global
market for siloxanes (silicones) will reach more than 19 billion dollars by the year 2017 (Chemical
Economics Handbook, 2013; Frust, 2014; Mojsiewicz-Pien´kowska, 2015). These indices suggest
that this is a very serious branch of the economy in many countries. Siloxanes are important object
of the research due to their widespread use not only by adults and children, but also by infants.
Currently, nearly 50% of new skin care products contain at least one type of silicone (Schalau and
Ulman, 2009). Due to the fact that siloxanes differ in particles size, molecular weight, shape and
physico-chemical properties, the discussion concerning their direct effect on safety or risk of an
application was undertaken in this study.
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CHARACTERISTICS OF SILOXANES
(SILICONES)
The Beginnings of Silicones Chemistry
and Contemporary Manufacturers
Thousands of scientific articles and patents have been created
since 1872, when the first siloxane polymer was obtained. A rapid
development of the synthesis of organosilicon compounds
was noted in subsequent years. Charles Friedel and James
Crafts obtained tetraethylsilane, which was the first compound
containing Si-C bond (Brook, 2000; Butts et al., 2002).
However, the greatest achievements in the field of synthesis
are attributed to Frederic Stanley Kipping, who in 1904 used
the Grignard reaction for the preparation of organosilicon
compounds, and discovered the intermolecular condensation of
silanols leading to obtain siloxanes and polysiloxanes. Rapid
development of silicones chemistry occurred in the thirties
of the 20th century. Technological breakthrough was the
development of so called direct methylchlorosilanes synthesis
method by Eugene Rochow in the United States in 1941
(Brook, 2000; Chojnowski and Cypryk, 2000; Butts et al.,
2002; Thomas, 2010). Methylchlorosilanes became the starting
compounds (monomers) in various preparation reactions of
silicones. The technology for direct synthesis was developed
nearly at the same time, in the year 1942 in Germany, under the
supervision of Richard Miller (Butts et al., 2002). The production
of silicones, the first generation of these unique polymers,
started during World War II in the USA in Dow Corning
Corporation (Chojnowski and Cypryk, 2000; Thomas, 2010).
Currently, the major leaders in silicones production include
the following companies: Wacker Chemie (Germany), Dow
Corning (USA), SiVance (USA), Shin-Etsu Chemical (Japan),
NuSil Technology (USA), Momentive Performance Materials
(USA), Evonik Industries (Germany), Qingdao Ocean Chemical
Co, Ltd (China), Bluestar Silicones (International Corporation),
Mizusawa Industrial Chemicals Ltd (Japan).
Chemical Structure and Particle
Geometry
Chemical structure of the compound, as well as particle size,
should be taken into account in safety evaluation of the use
of siloxanes. These two factors determine the physico-chemical
properties, which strictly correlate with the ability to interact with
the human organism, as well as the ability to pass through cellular
barriers.
Silicon (Si) as a chemical element is more electropositive than
carbon (C) and, like carbon, forms covalent bonds with different
elements, e.g., with oxygen (O) (siloxanes and polysiloxanes),
nitrogen (N) (silazanes and polysilazanes), sulfur (S) (siltianes
and polysiltianes), silicon (Si) (silanes and polysilanes), carbon
(C) (carbosilanes and polycarbosilanes) (Brook, 2000; Butts
et al., 2002). This is an element that forms a wide variety
of group of organosilicon compounds. Undoubtedly, the most
crucial group of organosilicon compounds are siloxanes, which
are commonly known as silicones. The name “silicones”
originates from a time when it was thought that siloxanes
have a structure analogous to the ketones Si = O. The
studies proved that silicon does not have the ability to create
stable double bonds. The correct structure of siloxanes is
described by the repeating group —[R2Si–O]— with usually
organic substituents at the silicon atom. Substituent R may
usually represent the groups such as: methyl, ethyl, propyl,
phenyl, fluoroalkyl, aminoalkyl, hydroxy, mercapto, hydrogen,
vinyl. The chemistry of siloxanes distinguishes four levels of
functionality, which, together with the type of functional groups,
determine structure geometry. These are the monofunctional
units (M) which act as terminators of the chains, difunctional
ones (D) which form the multiparticle skeleton of oligomers
and polymers linear chains, or cyclic compounds, trifunctional
(T) and tetrafunctional (Q), which result in branched and
spatially cross-linked molecules, observed in resins, rubbers
and elastomers (Tomanek, 1991; Fendinger et al., 1997; Kuo,
1999; Dow Corning, 2000–2016c; Butts et al., 2002; Colas and
Curtis, 2004; Omidian et al., 2011; Mojsiewicz-Pien´kowska,
2012, 2014). Siloxane molecule may be thus linear, cyclic,
branched or cross-linked (Figure 1) (Dow Corning, 2000–
2016a; Mojsiewicz-Pien´kowska, 2015). The characteristic of these
principal structures are presented in Table 1 (Chojnowski
and Cypryk, 2000; Dow Corning, 2000–2016a; Mojsiewicz-
Pien´kowska, 2015).
Comment
In conclusion, it should be noted that the safety of application
decreases with the decrease in silicone particle size. This is
due to the possibility to overcome biological membranes and
skin barriers by low molecular siloxanes, which demonstrate
a lipophilic character according to the rule of Lipinski. The
bioavailability and also permeation of compounds through the
skin layers is possible, when they meet the following conditions
(Lipinski, 2000; Lipinski et al., 2001; Mojsiewicz-Pien´kowska,
2014):
FIGURE 1 | Five basic structures of siloxanes.
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TABLE 1 | The characteristic of principal structures of siloxanes.
No. Structure Characteristic
1 Linear Volatile (e.g., dodecamethylpentasiloxane in cosmetics) and non-volatile liquids (e.g., dimethicone in oral capsules)
2 Cyclic Volatile liquids (e.g., cyclomethicone in hairspray or creams)
3 Branched Resins and rubbers, e.g., Soft Skin Adhesives from Dow-Corning company DC 7-9800 Part A, DC 7-9800 Part B in
silicone tapes on the skin, or in transdermal systems;
4 Cross-linked (first network) Resins, rubbers, elastomers (e.g., Cica-Care for the treatment of scars and keloids);
5 Cross-linked (second network) Resins readily transformed into a three-dimensional network)
(1) there are less than 5 hydrogen-bond donors (Expressed as
the sum of hydroxide groups OHs and amine groups NHs);
(2) molecular Weight is less than 500;
(3) the Log P is less than 5;
(4) there are less than 10 hydrogen-bond acceptors (expressed
as the sum of nitrogens and oxygens).
Therefore, consideration of siloxanes toxicity should be always
referred to a particular compound, which may be low molecular,
medium molecular (oligomer) or a high molecular weight
(polymer), but not to the entire chemical group. Actually, particle
size and chemical structure determine their physicochemical
properties (e.g., solubility, lipophilicity, log P, volatility), ability to
penetrate and permeate through skin layers, ability to overcome
cellular barriers and toxicity. Moreover, low molecular weight
silicones can change the structure of lipid bilayer, by the
fluidization or even extraction of the lipids (Glamowska et al.,
2015; Mojsiewicz-Pien´kowska et al., 2015; Yang and Guy, 2015).
This effect can weaken the natural barrier of cell membranes
(Glamowska et al., 2015; Mojsiewicz-Pien´kowska et al., 2015).
Low molecular weight silicones can accumulate in the organism,
and affect the organs in the long-term perspective (Wang et al.,
2013). The least safe are cyclic siloxanes and low molecular weight
linear siloxanes (Flassbeck et al., 2001; Gaubitz et al., 2002; Papp
et al., 2004; Tran et al., 2015; Xu et al., 2015). Additionally, their
volatility poses a threat of entering to the organism through
the respiratory system (Genualdi et al., 2011; Kierkegaard and
McLachlan, 2013; Tran et al., 2015; Xu et al., 2015).
Synthesis of Linear and Cyclic Siloxanes
and Polysiloxanes
The methods of siloxanes synthesis, and the possibility of
purification from reagents or intermediates, should be taken into
consideration in these compounds safety evaluation.
Siloxanes are generally obtained from monomers, such as:
methyltrichlorosilane, dimethyldichlorosilane, methylphenyldich-
lorosilane, diphenyldichlorosilane, or phenyltrichlorosilane
(Brook, 2000; Butts et al., 2002). In the chemical industry,
they are obtained using the three methods: Grignard method,
direct method using silicon reaction with an alkyl chloride
(so-called Rochow process using a copper catalyst) or using
an addition method (Brook, 2000; Clarson, 2003; Colas and
Curtis, 2004; Daum, 2005). The siloxanes are prepared in a few
stage process. Reactive monomers of chlorosilanes obtained
using one of the three mentioned methods are subjected to
hydrolysis with an excess water at a temperature range of
10–90◦C in organic solvents, e.g., esters and ketones. Continuous
hydrolysis of, e.g., dimethyldichlorosilane (Me2SiCl2) allows
to obtain a mixture of cyclic and linear hydroxyl-terminated
oligosiloxanes. The hydrolyzate is then processed in linear
dimethylsiloxane polymers in one of two industrial processes:
polymerization or condensation. Polymerization process
results in an opening of cyclic siloxanes ring, after the use
of cracking and H+ or OH− catalyst. It should be noted
that the hydrolyzate in the cracking process in the presence
of a strong base is first converted to a mixture of cyclic
monomers, especially octamethylcyclotetrasiloxane (D4) and
decamethylcyclopentasiloxane (D5), and ring opening occurs
after that. At the end of the reaction, the reactor contains the
mixture of linear polysiloxane and about 15% of cyclic oligomers
(Noll, 1968; Voronkov et al., 1978; Rubinsztajn et al., 1989;
Colas and Curtis, 2004). Polymerization of cyclic siloxanes was
elaborated in the US in the fifties by General Electric Co. and Dow
Corning (Noll, 1968; Rich et al., 1997). The polycondensation
of linear hydroxyl-terminated oligosiloxanes using a catalyst of
linear phosphonitrilic chloride produces linear high molecular
polymers. This process was developed in Germany and was used
on an industrial scale, e.g., in Wacker Chemie AG (Nitzsche and
Wick, 1958; Nitzsche et al., 1965). The polycondensation also
produces a mixture of linear polymers and cyclic oligomers, but
with a low content of about 2% (Nitzsche et al., 1974).
Comment
In conclusion, considering the safety of the direct application or
contact by humans with siloxanes, the polycondensation reaction
is preferred, due to lower contamination with low molecular
weight siloxanes of cyclic structure. The literature indicates
that they exhibit toxic effects, for example: cancerogenicity,
modifications in proteins conformation, influence on the
immune system, genotoxicity, skin irritations, intraocular
pressure increase and teratogenicity (Wang et al., 2013;
Mojsiewicz-Pien´kowska, 2014). Also the presence of low
molecular weight siloxanes with linear structure that are formed
during the course of synthesis stages, but are not efficiently
removed during the purification of oligomers and polymers,
e.g., by distillation, should be monitored. Moreover, except
from inefficient distillation, there is also another source of
contaminants. Longer chains can form, for example, so called
“traps” for low molecular weight compounds (with short chains),
impeding the distillation of both linear, and cyclic siloxanes
(Dow Corning). Figure 2 presents the scheme of a possibility
of siloxanes short chains trapping in the bundles of long chains
(Dow Corning, 2000–2016b). This is possible due to the fact, that
short and long chains are chemically compatible with each other.
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FIGURE 2 | Scheme of the possibility of siloxanes short chains
trapping in the bundles of longer chains: (A) Viscosity <10 000 cSt, small
chains entanglement; (B) Viscosity 60 000 cSt, moderate chains
entanglement, (C) Viscosity 30 000 000 cSt high chains entanglement.
Due to the specificity of siloxanes synthesis reaction, which
is the cause of formation of the chains with different numbers
of structural units in the molecule, the obtained product should
be treated not as a specific compound, but as a mixture of
polymers, oligomers, and even low molecular weight compounds
of different chain lengths and thus different molecular weights.
Although there is a predominant fraction of a specific degree of
polymerization in each sample after the synthesis, also referred
to as the dominant fraction, there is the possibility of low
molecular contamination occurrence. The mixture may also
include the siloxanes of cyclic structure (Mojsiewicz-Pien´kowska,
2014).
It should also be noted that human can have an undesired
contact with the low molecular weight siloxanes of the linear or
cyclic structure, not only in the form of contaminations. The
problem may result from a deliberate action of the manufacturers
to obtain the product with desired viscosity. The possibility of
trapping was used in industry in order to obtain specific viscosity
as a result of mixing of polymers with different degrees of
polymerization. There are even special diagrams facilitating
the selection of appropriate quantities of polysiloxanes for
the mixing (Catalog Gelest, 2012). Therefore, the viscosity
parameter, determining the physical characteristic of particular
analyte, is not sufficient to determine whether it deals, for
example, with active pharmaceutical ingredient (Dimeticone,
Simeticone) or a food additive (E-900) in accordance with
the standard (Mojsiewicz-Pien´kowska and Łukasiak, 2003;
Mojsiewicz-Pien´kowska, 2008, 2011, 2012, 2014).
Synthesis of Silicone Elastomers
The synthesis of the silicone elastomers involves the process
of vulcanization as a result of cross-linking the linear siloxane
polymers, so called reactive polymers. The cross-linking process
involves conversion of linear polymer molecules in the spatial
macromolecule, which is the consequence of cross-links, so
called bridges (nodes), formation between them. Parts A and
B of the individual components contribute in the chemical
reactions leading to rubber cross-linking. The cross-linker is
a multifunctional polysiloxane with hydrosilane substituent Si-
H, and the second one is the basic siloxane polymer with
vinyl groups (CH = CH2), containing Karstedt’s catalyst
Pt2{[(CH2 = CH)Me2Si]2O}3. The catalyst is a chemical
compound containing two platinum atoms, which attach two
divinyltetramethyldisiloxyl ligands, and one tetramethyldisiloxyl
addend connects both platinum atoms. The mixing of two
components A and B is followed by the quick addition reaction,
so called hydrosilylation. It involves the attachment of one
molecule to another which results in only one product, with no
by-products. The addition reaction takes place due to disruption
of multiple carbon–carbon bond of the vinyl moiety, and results
in silicon-carbon bond formation. Polyaddition reaction of Si-
H bonds to vinyl groups results in the formation of numerous
hydrocarbon bridges connecting the polysiloxane chains. This
is the type of cross-linking with their ends participation
(endlinking) (Mojsiewicz-Pien´kowska et al., 2011, 2015).
Comment
Having in mind the safety of direct application or contact by
humans with the siloxane (silicone) elastomers, it is necessary
to use reactive linear polymers free of contamination with cyclic
siloxanes, as well as low molecular polysiloxanes with linear
structure. When the cross-linking reaction involves rubbers
contaminated with cyclic siloxanes or low molecular linear
siloxanes, they are enclosed in the network. Figure 3 presents
the scheme of closing of the short chain of siloxanes with a
FIGURE 3 | Scheme of short chain siloxanes with a linear and cyclic structure closing in the elastomer network.
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linear, as well as cyclic structure, in elastomer’s network. This is
possible due to the fact that the elastomer has got some spaces
between cross-linked chains, so-called free permeable channels.
For example, in the contact with skin, the short chains of
polysiloxanes with a linear and cyclic structure can diffuse from
the elastomer into the stratum corneum and deeper layers of the
skin (Sanchez et al., 2003; Mojsiewicz-Pien´kowska et al., 2015).
Fundamental Siloxanes Characteristic
Related to Chemical Structure
Chemical structure of siloxanes caused that they are distinguished
by many features that allowed their dynamic development,
diversity and wide application. Especially significant is an unusual
static flexibility of siloxane chain manifested by a huge number
of available conformations, as well as dynamic flexibility related
to the ease of rapid conformational changes (Tiwari and Soucek,
2014). The extraordinary flexibility of polysiloxanes chain results
from relatively long Si-O (about 1.64 Å) and Si-C bonds (about
1.88 Å), and the lack of substituents at every second atom of
the chain. The flexibility of the chain facilitates rotation around
chemical bonds (Figure 4). The alternating location of Si and O
atoms results in a specific arrangement of electron interactions.
Si-O bond also has a high proportion of ionic character (about
50%), which causes higher strength of binding compared to the
equivalent of binding with C (De Buyl, 2001). The consequences
of mentioned effects are very low energy barrier of Si-O-Si angle
(<0.5 kcal/mol) and rotation around Si-O bond. This results in a
FIGURE 4 | Example of siloxane chain.
very fast relaxation of conformation stress, leading to adaptation
of chain conformation to ambient conditions (Salamone, 1996;
De Buyl, 2001; Luria, 2003; Lin et al., 2009; Pinto et al., 2010;
Mojsiewicz-Pien´kowska et al., 2015).
Siloxanes are also characterized by an amphiphilic character
(Figure 5). On the one side, there is an inorganic chain with
strong polar Si-O bonds, and on the other side non-polar organic
groups bonded to silicon atom (Mojsiewicz-Pien´kowska, 2015;
Physical and chemical properties of silicone). The amphiphilic
nature precisely plays an essential role in their unique properties.
An example can be the ability to form hydrogen bonds with
human skin, by contacting an inorganic part containing oxygen
atoms (Si-O), which act as hydrogen acceptors, or an organic
part (CH3), which represent hydrogen donors. This feature
determines the phenomenon of adhesion between the siloxane
elastomer and human skin (Mojsiewicz-Pien´kowska et al., 2011,
2015).
Siloxanes Characteristics Relevant for
Medical and Cosmetic Applications
The chemical structure is related to the characteristic features of
the siloxanes and polysiloxanes, which determine the beneficial
and unique properties. As a result, they are particularly used in
many areas of human life.
The specific characteristics of siloxanes which determine
their beneficial properties include strong Si-C and Si-O bonds,
free rotation of the chain, and partially ionic nature of the
siloxane bond. An ability of free rotation of the chain enables
an optimal orientation of, for example, alkyl groups on the
surface of oligomer or polymer. Hence, in contact with an
environment, the surface of the layer of low energy (e.g.,
dimethicone polydimethylsiloxane) is dominated by densely
packed methyl groups, which causes low energy and chemically
inert surface. The chemical inertness (lack of reactivity) is
also affected by strong Si-C and Si-O bonds (De Buyl, 2001;
Butts et al., 2002; Mojsiewicz-Pien´kowska, 2011, 2014, 2015).
This is particularly important for the safety of siloxanes and
polysiloxanes application in a direct contact with human
organism. In turn, ionic nature causes higher susceptibility to
heterolytic rupture, which contributes to the formation of cation
and anion, not radicals as in case of homolytic rupture (De Buyl,
FIGURE 5 | Ability to form hydrogen bonds with human skin as a result of the amphiphilic nature of siloxanes and adhesion of silicone elastomer to
the skin.
Frontiers in Pharmacology | www.frontiersin.org 5 May 2016 | Volume 7 | Article 132
fphar-07-00132 May 26, 2016 Time: 12:51 # 6
Mojsiewicz-Pien´kowska et al. Siloxanes (Silicones) – Safety or Risk Part 1
2001). This feature enhances the safety of siloxanes application in
contact with human organism.
Due to their dual nature (amphiphilic character), siloxanes are
also characterized by a quick diffusion at the interface, where
they obtain the conformation corresponding to the minimum
free energy of the surface, which makes it possible to create a thin,
highly adherent layer on it. Amphiphilic character (Figure 5)
affects thus a range of surface properties of siloxanes, which
results in a very broad applicability of these compounds. This
may cause a decrease in surface tension (e.g., oral activity of
dimethicone) or adhesion (e.g., Silicone Soft Skin Adhesive -SSA
elastomer) effect on the skin. When elastomers are in contact
with an air, then the pendant methyl groups are compressed by
the contact surface. This is an important phenomenon, since
methyl group determine the hydrophobic properties. In turn, in
case of the contact with water, the dipole of siloxane skeleton
is a predominant part, responsible for interactions between
the media. This causes that the surface of siloxane (silicone)
elastomer becomes more hydrophilic (Kurian et al., 2003).
This aspect is extremely essential in the understanding of the
differences in adhesion properties between silicone elastomers.
Moreover, trends of Si-O siloxane chain to a slight elongation
under a small force at a room or higher temperature, and recovery
to its original form after deflecting force elimination, optimize the
adhesion strength and allow, e.g., using silicone film on the skin
for a few hours (De Buyl, 2001; Mojsiewicz-Pien´kowska, 2011,
2014, 2015).
Siloxane (silicone) elastomers are a special group of
organopolysiloxanes used on the skin. They are all characterized
by different features, which demonstrate a positive therapeutic
effect, e.g., on keloids, hypertrophic scars. In this case, the
adhesive properties, ability to occlusion and diffusion gasses
(oxygen, water vapor), which are presumably the factors of
therapeutic action, were considered to be significant. The kind
of elastomer, conformation of the chains and degree of its
cross-linkage are important factors affecting its properties. One
of such features is the ability to permeate of gasses (oxygen, water
vapor), as well as the incorporation of medicinal substance and
its release. The rate of diffusion is dependent on the size of the
space formed between cross-linked chains and chains density
(degree of cross-linking). These are so called free permeable
channels. The larger the diameter of the channels in relation to
the size of water vapor, oxygen, or active ingredient particles,
or number of the channels, the easier and faster the diffusion
process. The formation of free permeable channels is possible
due to the high flexibility of Si-O bond, and thus flexibility of
siloxane chains, as well as their mobility and ability to deform
(De Buyl, 2001; Butts et al., 2002; Kurian et al., 2003; Zhang and
Cloud, 2006; Lin et al., 2009; Czech et al., 2011).
Table 2 presents the most important properties of siloxanes,
which cause their common application as an active compound
or auxiliary substance in medicinal products, medical devices,
and cosmetics (Kuo, 1999; De Buyl, 2001; Clarson, 2003; Lin
et al., 2009; Mojsiewicz-Pien´kowska, 2011, 2014, 2015; Tiwari and
Soucek, 2014).
SUMMARY
Generally, siloxanes (silicones) are well tolerated by the
human organism, and therefore they are an integral part of
innovative methods of treatment, health care and nursing.
They are commonly regarded as non-toxic to humans and the
environment, or toxic to a very small extend. However, there
is a number of publications in which the scientists and experts
question this opinion. Many authors demonstrated that the
degree of polymerization and the structure affect the ability
to overcome cellular barriers, including stratum corneum of
TABLE 2 | The most important features of siloxanes used in medicinal products, medical devices and cosmetics.
No. Siloxanes properties
General Conditioning medical and cosmetic application Conditioning medical application on skin
(elastomers)
1 Low toxicity No effect on the immune system Biocompatibility
2 Stability-resistance to temperature (−100 to 250◦C) No carcinogenic effect Highly non-toxic
3 Stability-resistance to atmospheric condition Do not irritate skin or have low irritation Ability to adhesion
4 Stability-aging resistance Do not foster the growth of microorganisms Anti-adhesion
5 Stability-resistance to oxidation Safety of application due to the lack of penetration through
cell membranes
Ability to permeation of water vapor and oxygen
6 Stability-resistance to moisture Similar to hydrophilic/lipophilic properties of human skin Ability to skin occlusion
7 Stability-resistance to UV radiation Lack of reactivity with respect to the active pharmaceutical
ingredient and excipients
Hydration of stratum corneum
8 Resistance to degradation Similarity to biological membranes Possibility of the diffusion of the active
substance
9 Low chemical reactivity Clearness, colorless, odorless Transparency
10 Low surface energy Easy spreading Non-visible on the skin
11 Low surface tension Low heat of vaporization Resistance to extensibility and deformation
12 Smooth texture Compatible with a wide range of solvents Flexibility
13 Hydrophobicity Imparts a soft-silky feel to the skin
14 Water repellent
15 Hydrophilicity
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the skin and absorption into the organism, migration in the
living organism, ability to accumulate, degradability and toxicity.
This particularly applies to low molecular weight siloxanes. It
can be concluded in the summary, that an evaluation of the
safety of siloxanes application should always refer to a particular
compound, not a chemical group. Furthermore, the use of low
molecular weight silicones should be reduced, as well as the
purity of high molecular weight silicones, which may contain
low molecular compounds as impurities, should be monitored.
It should be emphasized that in the case of silicones for medical
and pharmaceutical use, the manufactures of this group of
compounds formed a special class, which they called “Medical
Grade Silicones” or “Silicones for Healthcare Application.” These
silicones must meet certain standards. Medical grade silicones
are specially designed, produced and purified, so that to meet
the highest requirements of the medical industry. The detailed
toxicity data and information about “Medical Grade Silicones”
and “Silicones for Healthcare Application” will be given in the
next parts of this cycle.
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